Latest Life Biosciences News & Updates

See the latest news and media coverage for Life Biosciences. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Life Biosciences

Biotechnology company developing cellular rejuvenation therapies

lifebiosciences.com
Headquarters
Boston, United States
Founded year
2017
Company type
Private company
Number of employees
25–50

Last updated

Latest news about Life Biosciences

In short: Life Biosciences secured $80 million in Series D funding and received FDA clearance to begin human clinical trials for its lead therapy, ER-100.

Company announcements

  • Life Biosciences

    Life Biosciences features in TIME100 Companies list

    The recognition highlights their work reversing age-related diseases via epigenetic reprogramming. They remain committed to advancing transformative science.

  • Life Biosciences

    Life Biosciences secures $80 million Series D financing

    Funding supports Phase 1 trial of ER-100 for optic neuropathies and advances Partial Epigenetic Reprogramming platform. Announced April 8, 2026.

  • Life Biosciences

    Life Biosciences' CSO discusses cellular rejuvenation

    Sharon Rosenzweig-Lipson highlights IND clearance for lead therapy advancing to clinic to restore visual function in optic neuropathies.

  • Life Biosciences

    Life Biosciences' CSO contributes to article on reprogramming

    She discusses OSK-based platform and upcoming Phase 1 trial for age-related optic neuropathies.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Life Biosciences

Track Life Biosciences and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Life Biosciences competitors & trending companies

Browse news for competitors to Life Biosciences and other trending companies.